Form 8-K - Current report:
SEC Accession No. 0001193125-25-273321
Filing Date
2025-11-10
Accepted
2025-11-10 08:05:14
Documents
12
Period of Report
2025-11-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d25083d8k.htm   iXBRL 8-K 24916
  Complete submission text file 0001193125-25-273321.txt   135536

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20251108.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20251108_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20251108_pre.xml EX-101.PRE 10821
15 EXTRACTED XBRL INSTANCE DOCUMENT d25083d8k_htm.xml XML 3521
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 251464447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)